Rosenblum Silverman Sutton Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BellRing Brands
BRBR
|
+$2.18M |
| 2 |
SGI
Somnigroup International
SGI
|
+$853K |
| 3 |
RTX Corp
RTX
|
+$335K |
| 4 |
JPMorgan Chase
JPM
|
+$219K |
| 5 |
Citigroup
C
|
+$102K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
A.O. Smith
AOS
|
+$3.71M |
| 2 |
Constellation Brands
STZ
|
+$3.04M |
| 3 |
Heron Therapeutics
HRTX
|
+$1.34M |
| 4 |
Adobe
ADBE
|
+$1.25M |
| 5 |
Analog Devices
ADI
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.27% |
| 2 | Healthcare | 16.59% |
| 3 | Consumer Discretionary | 16.35% |
| 4 | Financials | 12.92% |
| 5 | Communication Services | 11.48% |
Similar funds
Rosenblum Silverman Sutton's Q4 2019 Portfolio in Review
As of Q4 2019, Rosenblum Silverman Sutton held 58 positions worth $274M, up 5.6% from $260M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Rosenblum Silverman Sutton withdrew a net $11.7M in Q4 2019, closing 3 positions and reducing 43 holdings. Its most notable exit was A.O. Smith, an estimated $3.71M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Rosenblum Silverman Sutton opened a new position in BellRing Brands worth $2.37M.
- Rosenblum Silverman Sutton's largest Q4 2019 buy was BellRing Brands: 111,210 shares worth $2.37M.
- Rosenblum Silverman Sutton added most to Somnigroup International in Q4 2019, an estimated $853K increase.
- Rosenblum Silverman Sutton's biggest Q4 2019 reduction was Constellation Brands, cutting an estimated $3.04M.
- Rosenblum Silverman Sutton fully exited A.O. Smith in Q4 2019, selling an estimated $3.71M.
- Rosenblum Silverman Sutton's ten largest holdings make up 43% of its $274M portfolio in Q4 2019.
- Rosenblum Silverman Sutton opened 1 new position and closed 3 in Q4 2019.
- Rosenblum Silverman Sutton's portfolio value rose 5.6% quarter-over-quarter to $274M.
Based on Rosenblum Silverman Sutton's 13F filing for Q4 2019, filed 24 Jan 2020.